• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同时给予狂犬病免疫球蛋白对仓鼠中商业和候选人类狂犬病疫苗免疫原性的抑制作用。

Inhibitory effect of concomitantly administered rabies immunoglobulins on the immunogenicity of commercial and candidate human rabies vaccines in hamsters.

机构信息

Research & Development, Sanofi, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280, Marcy L'Etoile, France.

出版信息

Sci Rep. 2022 Apr 21;12(1):6570. doi: 10.1038/s41598-022-10281-1.

DOI:10.1038/s41598-022-10281-1
PMID:35449223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9023498/
Abstract

The World Health Organization protocol for rabies post-exposure prophylaxis (PEP) recommends extensive wound washing, immediate vaccination, and administration of rabies immunoglobulin (RIG) in severe category III exposures. Some studies have shown that RIG can interfere with rabies vaccine immunogenicity to some extent. We investigated the interference of RIG on a next generation highly purified Vero cell rabies vaccine candidate (PVRV-NG) versus standard-of-care vaccines in a previously described hamster model. The interference of either human (h) or equine (e) RIG on the immune response elicited by PVRV-NG, Verorab (purified Vero cell rabies vaccine, PVRV), and Imovax Rabies (human diploid cell rabies vaccine; HDCV) was evaluated using the 4-dose Essen PEP regimen. The anti-rabies seroneutralizing titers and specific serum IgM titers were measured by fluorescent antibody virus neutralization test and enzyme-linked immunosorbent assay, respectively, for the vaccines administered with or without RIG. The RIG interference on PVRV-NG, observed transiently at Day 7, was similar to that on PVRV and tended to be lower than that on HDCV using both read-outs. In summary, the results generated in the hamster model showed that RIG induced similar or less interference on PVRV-NG than the standard-of-care vaccines.

摘要

世界卫生组织狂犬病暴露后预防(PEP)方案建议在严重的 III 类暴露中进行广泛的伤口清洗、立即接种疫苗和狂犬病免疫球蛋白(RIG)的使用。一些研究表明,RIG 在某种程度上会干扰狂犬病疫苗的免疫原性。我们在先前描述的仓鼠模型中研究了 RIG 对下一代高度纯化的 Vero 细胞狂犬病疫苗候选物(PVRV-NG)与标准护理疫苗的干扰作用。使用 4 剂 Essen PEP 方案评估了 hRIG 或 eRIG 对 PVRV-NG、Verorab(纯化 Vero 细胞狂犬病疫苗,PVRV)和 Imovax Rabies(人二倍体细胞狂犬病疫苗;HDCV)引发的免疫反应的干扰作用。通过荧光抗体病毒中和试验和酶联免疫吸附试验分别测量狂犬病血清中和抗体滴度和特异性血清 IgM 滴度,用于评估与 RIG 联合或不联合使用的疫苗。在第 7 天观察到的对 PVRV-NG 的 RIG 干扰是短暂的,与 PVRV 的干扰相似,并且与两种检测结果相比,对 HDCV 的干扰趋于更低。总之,在仓鼠模型中产生的结果表明,RIG 对 PVRV-NG 的干扰与标准护理疫苗相似或更小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e0/9023498/c9097640ccd7/41598_2022_10281_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e0/9023498/511cacd755ec/41598_2022_10281_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e0/9023498/8fc747622e7c/41598_2022_10281_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e0/9023498/8ea250ff7878/41598_2022_10281_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e0/9023498/c9097640ccd7/41598_2022_10281_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e0/9023498/511cacd755ec/41598_2022_10281_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e0/9023498/8fc747622e7c/41598_2022_10281_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e0/9023498/8ea250ff7878/41598_2022_10281_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e0/9023498/c9097640ccd7/41598_2022_10281_Fig4_HTML.jpg

相似文献

1
Inhibitory effect of concomitantly administered rabies immunoglobulins on the immunogenicity of commercial and candidate human rabies vaccines in hamsters.同时给予狂犬病免疫球蛋白对仓鼠中商业和候选人类狂犬病疫苗免疫原性的抑制作用。
Sci Rep. 2022 Apr 21;12(1):6570. doi: 10.1038/s41598-022-10281-1.
2
Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults.在健康成年人中,模拟狂犬病暴露后方案中,比较无血清纯化 Vero 狂犬病疫苗与狂犬病人二倍体细胞疫苗(HDCV;Imovax® Rabies)的安全性和免疫原性。
Vaccine. 2024 Apr 11;42(10):2553-2559. doi: 10.1016/j.vaccine.2023.11.052. Epub 2023 Dec 16.
3
Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial.在法国健康成年人的模拟狂犬病暴露后治疗方案中,一种纯化的无血清Vero狂犬病疫苗与两种已获许可疫苗相比的免疫原性和安全性:一项随机、对照、3期试验。
Clin Infect Dis. 2024 Jun 14;78(6):1748-1756. doi: 10.1093/cid/ciae137.
4
Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults.一种新型高度纯化 Vero 细胞狂犬病疫苗三种剂量的安全性和免疫原性:在健康成年人中进行的一项随机、对照、观察者盲法、Ⅱ期研究,模拟了暴露后方案。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2275453. doi: 10.1080/21645515.2023.2275453. Epub 2023 Nov 3.
5
Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines.皮内暴露后狂犬病疫苗接种用纯化 Vero 细胞狂犬病疫苗:在菲律宾一项随机非劣效性试验中,比较一周 4 部位方案与泰国红十字会更新方案。
Vaccine. 2019 Apr 10;37(16):2268-2277. doi: 10.1016/j.vaccine.2019.02.083. Epub 2019 Mar 16.
6
A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China.在中国,健康儿童和成年人按照接触后程序接种时,新一代、无血清、高度纯化的 Vero 细胞狂犬病疫苗具有良好的安全性,其免疫原性与对照疫苗 Verorab®相当。
Vaccine. 2013 Dec 5;31(50):5940-7. doi: 10.1016/j.vaccine.2013.10.043. Epub 2013 Oct 19.
7
A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.一项随机、开放性标签研究,旨在证明在中国人中,采用萨格勒布方案(2-1-1)接种纯化鸡胚细胞狂犬病疫苗与埃森方案相比具有非劣效性。
Hum Vaccin Immunother. 2014;10(10):2805-12. doi: 10.4161/21645515.2014.972773.
8
Safety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: A randomised phase II pre-exposure prophylaxis study.健康成年人无血清纯化 Vero 狂犬病疫苗的安全性和免疫原性:一项随机、II 期、暴露前预防性研究。
Vaccine. 2022 Aug 5;40(33):4780-4787. doi: 10.1016/j.vaccine.2022.06.040. Epub 2022 Jun 28.
9
A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial.一种无血清、纯化的vero 细胞狂犬病疫苗在健康成年人中的暴露前使用是安全的,与参考疫苗 Verorab 一样具有免疫原性:一项随机对照的 II 期临床试验结果。
Vaccine. 2013 Apr 26;31(18):2295-301. doi: 10.1016/j.vaccine.2013.02.058. Epub 2013 Mar 16.
10
One-week intramuscular or intradermal pre-exposure prophylaxis with human diploid cell vaccine or Vero cell rabies vaccine, followed by simulated post-exposure prophylaxis at one year: A phase III, open-label, randomized, controlled trial to assess immunogenicity and safety.一周肌肉或皮内注射人二倍体细胞疫苗或 Vero 细胞狂犬病疫苗,然后在一年后进行模拟暴露后预防:一项评估免疫原性和安全性的 III 期、开放性、随机、对照试验。
Vaccine. 2022 Aug 26;40(36):5347-5355. doi: 10.1016/j.vaccine.2022.07.037. Epub 2022 Aug 3.

引用本文的文献

1
Infection and Prevention of Rabies Viruses.狂犬病病毒的感染与预防
Microorganisms. 2025 Feb 9;13(2):380. doi: 10.3390/microorganisms13020380.
2
Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial.在法国健康成年人的模拟狂犬病暴露后治疗方案中,一种纯化的无血清Vero狂犬病疫苗与两种已获许可疫苗相比的免疫原性和安全性:一项随机、对照、3期试验。
Clin Infect Dis. 2024 Jun 14;78(6):1748-1756. doi: 10.1093/cid/ciae137.
3
Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults.

本文引用的文献

1
Safety and efficacy of rabies immunoglobulin in pediatric patients with suspected exposure.疑似暴露后儿童患者使用狂犬病免疫球蛋白的安全性和有效性。
Hum Vaccin Immunother. 2021 Jul 3;17(7):2090-2096. doi: 10.1080/21645515.2020.1854000. Epub 2021 Feb 9.
2
Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial.在健康受试者中,人免疫球蛋白(HRIG;凯德瑞)与活性疫苗联合使用进行模拟暴露后预防的安全性和有效性结果:一项2/3期对照试验。
Hum Vaccin Immunother. 2020;16(2):452-459. doi: 10.1080/21645515.2019.1656967. Epub 2019 Sep 24.
3
一种新型高度纯化 Vero 细胞狂犬病疫苗三种剂量的安全性和免疫原性:在健康成年人中进行的一项随机、对照、观察者盲法、Ⅱ期研究,模拟了暴露后方案。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2275453. doi: 10.1080/21645515.2023.2275453. Epub 2023 Nov 3.
4
Case Report: Survival from Clinical Rabies in a Young Child from Maharashtra, India, 2022.病例报告:2022 年,印度马哈拉施特拉邦一名幼儿成功从临床狂犬病中存活。
Am J Trop Med Hyg. 2023 Oct 2;109(5):1157-1160. doi: 10.4269/ajtmh.22-0683. Print 2023 Nov 1.
Rabies vaccines: WHO position paper, April 2018 - Recommendations.
狂犬病疫苗:世界卫生组织立场文件,2018 年 4 月-建议。
Vaccine. 2018 Sep 5;36(37):5500-5503. doi: 10.1016/j.vaccine.2018.06.061. Epub 2018 Aug 11.
4
Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis.暴露后预防狂犬病用纯化鸡胚细胞疫苗:系统文献回顾和荟萃分析。
Expert Rev Vaccines. 2018 Jun;17(6):525-545. doi: 10.1080/14760584.2018.1473765. Epub 2018 Jun 25.
5
Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study.新型人用狂犬病单抗与狂犬病免疫球蛋白用于狂犬病暴露后预防的比较:一项 2/3 期、随机、单盲、非劣效、对照研究。
Clin Infect Dis. 2018 Jan 18;66(3):387-395. doi: 10.1093/cid/cix791.
6
Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study.印度和德国生产的纯化鸡胚细胞狂犬病疫苗的免疫原性和安全性比较:一项随机、单盲、多中心、IV期临床研究。
Hum Vaccin Immunother. 2017 Jul 3;13(7):1531-1538. doi: 10.1080/21645515.2017.1307483. Epub 2017 Apr 13.
7
Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis.用于狂犬病暴露后预防的广谱人源单克隆抗体的研发。
EMBO Mol Med. 2016 Apr 1;8(4):407-21. doi: 10.15252/emmm.201505986.
8
Estimating the global burden of endemic canine rabies.估算地方性犬类狂犬病的全球负担。
PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003709. doi: 10.1371/journal.pntd.0003709. eCollection 2015 Apr.
9
Evaluation of a rabies ELISA as an alternative method to seroneutralisation tests in the context of international trade of domestic carnivores.评估狂犬病 ELISA 作为国际贸易中家养食肉动物血清中和试验替代方法的研究。
J Virol Methods. 2014 Jan;195:211-20. doi: 10.1016/j.jviromet.2013.10.021. Epub 2013 Oct 23.
10
A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China.在中国,健康儿童和成年人按照接触后程序接种时,新一代、无血清、高度纯化的 Vero 细胞狂犬病疫苗具有良好的安全性,其免疫原性与对照疫苗 Verorab®相当。
Vaccine. 2013 Dec 5;31(50):5940-7. doi: 10.1016/j.vaccine.2013.10.043. Epub 2013 Oct 19.